Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.

× No keyword cloud information.

8 in total

Review 1. Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.

Authors: David Aguilera-Alonso; Luis Escosa-García; Jesús Saavedra-Lozano; Emilia Cercenado; Fernando Baquero-Artigao
Journal: Antimicrob Agents Chemother Date: 2020-02-21 Impact factor: 5.191

Review 2. Fosfomycin.

Authors: Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal: Clin Microbiol Rev Date: 2016-04 Impact factor: 26.132

Review 3. Antibiotic-resistant gram-negative bacterial infections in patients with cancer.

Authors: Federico Perez; Javier Adachi; Robert A Bonomo
Journal: Clin Infect Dis Date: 2014-11-15 Impact factor: 9.079

Review 4. A new strategy to fight antimicrobial resistance: the revival of old antibiotics.

Authors: Nadim Cassir; Jean-Marc Rolain; Philippe Brouqui
Journal: Front Microbiol Date: 2014-10-20 Impact factor: 5.640

Review 5. Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens.

Authors: Chang-Seop Lee; Yohei Doi
Journal: Infect Chemother Date: 2014-09-24

Review 6. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.

Authors: Ilias Karaiskos; Helen Giamarellou
Journal: Expert Opin Pharmacother Date: 2014-04-28 Impact factor: 3.889

7. Cure of Limb-Threatening XDR Pseudomonas aeruginosa Infection: Combining Genome Sequencing, Therapeutic Drug Level Monitoring, and Surgical Debridement.

Authors: Shanti Narayanasamy; Roger L Nation; Andrew A Mahony; M Lindsay Grayson; Jason C Kwong; Norelle L Sherry; Sharmila Khumra; Andrew G Ellis; Albert G Frauman; Natasha E Holmes
Journal: Open Forum Infect Dis Date: 2020-11-26 Impact factor: 3.835

8. In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae.

Authors: Wei Yu; Kai Zhou; Lihua Guo; Jinru Ji; Tianshui Niu; Tingting Xiao; Ping Shen; Yonghong Xiao
Journal: Front Cell Infect Microbiol Date: 2017-06-16 Impact factor: 5.293

8 in total